Search 

Sygnature Discovery is the UK’s largest independent provider of integrated drug discovery resource and expertise. Our mission is to accelerate the discovery of new medicines from the laboratory into development to treat patients with a range of debilitating and fatal diseases. 

Syne qua non, established in 1996, is one of the largest functional biometrics suppliers in Europe providing global pharma, biotech, medical device and animal health partners with innovative, cost effective development services specializing in: • clinical data management through optimal process design with paper or EDC data capture solutions • statistical expertise through consultative study design to reporting • effective project management • quality management and consultancy Built on a foundation of CDISC standardization, our flexible and site-friendly EDC tool can be rapidly developed, validated and deployed – built to meet the unique requirements of the study and, coupled with our approach to standardization across all services, will deliver high quality data and in-stream reporting within a competitive pricing model.